share_log

Nephron Research Upgrades Bright Health Gr to Buy, Announces $85 Price Target

Nephron Research Upgrades Bright Health Gr to Buy, Announces $85 Price Target

Nepron Research 将 Bright Health Gr 升级为买入,宣布目标
Benzinga ·  2023/06/30 10:38

Nephron Research analyst Joshua Raskin upgrades Bright Health Gr (NYSE:BHG) from Hold to Buy and announces $85 price target.

Nepron Research分析师约书亚·拉斯金将Bright Health Gr(纽约证券交易所代码:BHG)从持有上调至买入,并宣布了85美元的目标股

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发